296 related articles for article (PubMed ID: 33582664)
1. Colchicine for Left Ventricular Infarct Size Reduction in Acute Myocardial Infarction: A Phase II, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Protocol - The COVERT-MI Study.
Bresson D; Roubille F; Prieur C; Biere L; Ivanes F; Bouleti C; Dubreuil O; Rioufol G; Boutitie F; Sideris G; Elbaz M; Bochaton T; De Bourguignon C; El Jonhy N; Dufay N; Dhelens C; Croisille P; Prunier F; Angoulvant D; Ovize M; Maucort-Boulch D; Mewton N
Cardiology; 2021; 146(2):151-160. PubMed ID: 33582664
[TBL] [Abstract][Full Text] [Related]
2. Effects of Compound Danshen Dripping Pills on Ventricular Remodeling and Cardiac Function after Acute Anterior Wall ST-Segment Elevation Myocardial Infarction (CODE-AAMI): Protocol for a Randomized Placebo-Controlled Trial.
Wu YJ; Deng B; Wang SB; Qiao R; Zhang XW; Lu Y; Wang L; Gu SZ; Zhang YQ; Li KQ; Yu ZL; Wu LX; Zhao SB; Zhou SL; Yang Y; Wang LS
Chin J Integr Med; 2023 Dec; 29(12):1059-1065. PubMed ID: 37656413
[TBL] [Abstract][Full Text] [Related]
3. Colchicine to Prevent Sympathetic Denervation after an Acute Myocardial Infarction: The COLD-MI Trial Protocol.
Huet F; Delbaere Q; Aguilhon S; Dupasquier V; Delseny D; Gervasoni R; Macia JC; Leclercq F; Jammoul N; Kahlouche S; Soltani S; Cardon F; Dupuy AM; Cristol JP; Mariano-Goulart D; Akodad M; Nagot N; Roubille F
Medicina (Kaunas); 2021 Sep; 57(10):. PubMed ID: 34684084
[TBL] [Abstract][Full Text] [Related]
4. Rationale and design of the Cyclosporine to ImpRove Clinical oUtcome in ST-elevation myocardial infarction patients (the CIRCUS trial).
Mewton N; Cung TT; Morel O; Cayla G; Bonnefoy-Cudraz E; Rioufol G; Angoulvant D; Guerin P; Elbaz M; Delarche N; Coste P; Vanzetto G; Metge M; Aupetit JF; Jouve B; Motreff P; Tron C; Labeque JN; Steg PG; Cottin Y; Range G; Clerc J; Coussement P; Prunier F; Moulin F; Roth O; Belle L; Dubois P; Barragan P; Gilard M; Piot C; Colin P; Morice MC; Monassier JP; Ider O; Dubois-Randé JL; Unterseeh T; Lebreton H; Beard T; Blanchard D; Grollier G; Malquarti V; Staat P; Sudre A; Hansson MJ; Elmer E; Boussaha I; Jossan C; Torner A; Claeys M; Garcia-Dorado D; Ovize M;
Am Heart J; 2015 Jun; 169(6):758-766.e6. PubMed ID: 26027612
[TBL] [Abstract][Full Text] [Related]
5. Mineralocorticoid receptor antagonist pretreatment to MINIMISE reperfusion injury after ST-elevation myocardial infarction (the MINIMISE STEMI Trial): rationale and study design.
Bulluck H; Fröhlich GM; Mohdnazri S; Gamma RA; Davies JR; Clesham GJ; Sayer JW; Aggarwal RK; Tang KH; Kelly PA; Jagathesan R; Kabir A; Robinson NM; Sirker A; Mathur A; Blackman DJ; Ariti C; Krishnamurthy A; White SK; Meier P; Moon JC; Greenwood JP; Hausenloy DJ
Clin Cardiol; 2015 May; 38(5):259-66. PubMed ID: 25990305
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
[TBL] [Abstract][Full Text] [Related]
7. Platelet inhibition to target reperfusion injury trial: Rationale and study design.
Bulluck H; Chan MHH; Bryant JA; Chai P; Chawla A; Chua TS; Chung YC; Fei G; Ho HH; Ho AFW; Hoe AJ; Imran SS; Lee CH; Lim SH; Liew BW; Yun PLZ; Hock MOE; Paradies V; Roe MT; Teo L; Wong AS; Wong E; Wong PE; Watson T; Chan MY; Tan JW; Hausenloy DJ
Clin Cardiol; 2019 Jan; 42(1):5-12. PubMed ID: 30421441
[TBL] [Abstract][Full Text] [Related]
8. Effect of Colchicine on Myocardial Injury in Acute Myocardial Infarction.
Mewton N; Roubille F; Bresson D; Prieur C; Bouleti C; Bochaton T; Ivanes F; Dubreuil O; Biere L; Hayek A; Derimay F; Akodad M; Alos B; Haider L; El Jonhy N; Daw R; De Bourguignon C; Dhelens C; Finet G; Bonnefoy-Cudraz E; Bidaux G; Boutitie F; Maucort-Boulch D; Croisille P; Rioufol G; Prunier F; Angoulvant D
Circulation; 2021 Sep; 144(11):859-869. PubMed ID: 34420373
[TBL] [Abstract][Full Text] [Related]
9. Effect of comprehensive remote ischemic conditioning in anterior ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Design and rationale of the CORIC-MI randomized trial.
Song L; Yan H; Zhou P; Zhao H; Liu C; Sheng Z; Tan Y; Yi C; Li J; Zhou J
Clin Cardiol; 2018 Aug; 41(8):997-1003. PubMed ID: 29726013
[TBL] [Abstract][Full Text] [Related]
10. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial.
Crimi G; Pica S; Raineri C; Bramucci E; De Ferrari GM; Klersy C; Ferlini M; Marinoni B; Repetto A; Romeo M; Rosti V; Massa M; Raisaro A; Leonardi S; Rubartelli P; Oltrona Visconti L; Ferrario M
JACC Cardiovasc Interv; 2013 Oct; 6(10):1055-63. PubMed ID: 24156966
[TBL] [Abstract][Full Text] [Related]
11. Intra-coronary morphine versus placebo in the treatment of acute ST-segment elevation myocardial infarction: the MIAMI randomized controlled trial.
Le Corvoisier P; Gallet R; Lesault PF; Audureau E; Paul M; Ternacle J; Ghostine S; Champagne S; Arrouasse R; Bitari D; Mouillet G; Dubois-Randé JL; Berdeaux A; Ghaleh B; Deux JF; Teiger E
BMC Cardiovasc Disord; 2018 Oct; 18(1):193. PubMed ID: 30340532
[TBL] [Abstract][Full Text] [Related]
12. Early Intravenous Beta-Blockers in Patients With ST-Segment Elevation Myocardial Infarction Before Primary Percutaneous Coronary Intervention.
Roolvink V; Ibáñez B; Ottervanger JP; Pizarro G; van Royen N; Mateos A; Dambrink JE; Escalera N; Lipsic E; Albarran A; Fernández-Ortiz A; Fernández-Avilés F; Goicolea J; Botas J; Remkes W; Hernandez-Jaras V; Kedhi E; Zamorano JL; Navarro F; Alfonso F; García-Lledó A; Alonso J; van Leeuwen M; Nijveldt R; Postma S; Kolkman E; Gosselink M; de Smet B; Rasoul S; Piek JJ; Fuster V; van 't Hof AWJ;
J Am Coll Cardiol; 2016 Jun; 67(23):2705-2715. PubMed ID: 27050189
[TBL] [Abstract][Full Text] [Related]
13. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794
[TBL] [Abstract][Full Text] [Related]
14. Effects of Nicorandil Administration on Infarct Size in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: The CHANGE Trial.
Qian G; Zhang Y; Dong W; Jiang ZC; Li T; Cheng LQ; Zou YT; Jiang XS; Zhou H; A X; Li P; Chen ML; Su X; Tian JW; Shi B; Li ZZ; Wu YQ; Li YJ; Chen YD
J Am Heart Assoc; 2022 Sep; 11(18):e026232. PubMed ID: 36073634
[TBL] [Abstract][Full Text] [Related]
15. Empagliflozin and colchicine in patients with reduced left ventricular ejection fraction following ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: a study protocol for a randomized, double-blinded, three-arm parallel-group, controlled trial.
Khiali S; Taban-Sadeghi M; Sarbakhsh P; Khezerlouy-Aghdam N; Namdar H; Salehi R; Rezagholizadeh A; Entezari-Maleki T
Trials; 2023 Oct; 24(1):645. PubMed ID: 37803449
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: rationale and design of the evaluation of MCC-135 for left ventricular salvage in acute MI (EVOLVE) study.
Jang IK; Pettigrew V; Picard MH; Kowey PR; Demmel V; Zile MR; Tatsuno J; Wackers FJ; Hibberd M
J Thromb Thrombolysis; 2005 Dec; 20(3):147-53. PubMed ID: 16261287
[TBL] [Abstract][Full Text] [Related]
17. Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial.
Najjar SS; Rao SV; Melloni C; Raman SV; Povsic TJ; Melton L; Barsness GW; Prather K; Heitner JF; Kilaru R; Gruberg L; Hasselblad V; Greenbaum AB; Patel M; Kim RJ; Talan M; Ferrucci L; Longo DL; Lakatta EG; Harrington RA;
JAMA; 2011 May; 305(18):1863-72. PubMed ID: 21558517
[TBL] [Abstract][Full Text] [Related]
18. Mineralocorticoid receptor antagonist pre-treatment and early post-treatment to minimize reperfusion injury after ST-elevation myocardial infarction: The MINIMIZE STEMI trial.
Bulluck H; Fröhlich GM; Nicholas JM; Mohdnazri S; Gamma R; Davies J; Sirker A; Mathur A; Blackman D; Garg P; Moon JC; Greenwood JP; Hausenloy DJ
Am Heart J; 2019 May; 211():60-67. PubMed ID: 30893577
[TBL] [Abstract][Full Text] [Related]
19. Rationale and design of EXPLORE: a randomized, prospective, multicenter trial investigating the impact of recanalization of a chronic total occlusion on left ventricular function in patients after primary percutaneous coronary intervention for acute ST-elevation myocardial infarction.
van der Schaaf RJ; Claessen BE; Hoebers LP; Verouden NJ; Koolen JJ; Suttorp MJ; Barbato E; Bax M; Strauss BH; Olivecrona GK; Tuseth V; Glogar D; Råmunddal T; Tijssen JG; Piek JJ; Henriques JP;
Trials; 2010 Sep; 11():89. PubMed ID: 20858263
[TBL] [Abstract][Full Text] [Related]
20. Trial design and rationale of TY-51924 as a novel Na+/H+ exchanger inhibitor in patients with ST-elevation acute myocardial infarction undergoing percutaneous coronary intervention.
Ishihara M; Asakura M; Kimura K; Nakao K; Hamada C; Hirayama A
J Cardiol; 2014 Jan; 63(1):82-7. PubMed ID: 23860273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
